Simplify Logo

Full-Time

Associate Director

Protein Engineering

Posted on 6/11/2024

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Biotechnology firm creating health and sustainability solutions

Venture Capital

Expert

Cambridge, MA, USA

Category
Computational Biology
Biology & Biotech
Requirements
  • Ph.D. in structural virology/biology, biochemistry, or a related field
  • 10+ years of post-Ph.D. experience (preferably 5+ in industry)
  • Experience working with SARS-CoV-2 spike, Influenza hemagglutinin, or other viral entry glycoproteins
  • Expertise in computational protein design and engineering (e.g. Rosetta, AlphaFold)
  • Experience with expression, purification, and biochemical characterization of designed recombinant proteins
  • Experience managing or leading people and teams
  • Familiarity with vaccines and vaccinology
  • Excellent communication and presentation skills
  • Comfortable delivering against challenging timelines
Responsibilities
  • Designing, planning, and executing/overseeing experiments supporting research activities and project goals
  • Leading structural design, expression, and validation of novel vaccine antigens
  • Collaborating across teams to generate data for iterative improvement of vaccine antigen designs
  • Managing and inspiring people or teams to deliver on goals and corporate milestones
  • Managing external relationships with contract research organizations
  • Communicating efforts and progress to internal and external parties

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$6.4B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.
INACTIVE